首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Pedro Ochoa-Allemant,Rebecca A Hubbard,David E Kaplan et al. Pedro Ochoa-Allemant et al.
Objective: To compare the risks of adverse liver outcomes, major adverse cardiovascular events (MACE), and all-cause mortality across steatotic liver disease subtypes.
Tuğba Çetin,Mehmet Baran Karataş,Semih Eren et al. Tuğba Çetin et al.
However, the relationship between the administration time of these drugs during the day and cardiovascular events is not yet fully elucidated....Primary endpoints were acute heart failure (AHF), nonfatal myocardial infarction, major adverse cardiovascular events (MACE), and long-term mortality.
Nicolas Johner,Baris Gencer Nicolas Johner
Introduction: Beta-blocker therapy reduced mortality and cardiovascular events following acute coronary syndromes (ACS) in the pre-reperfusion era.
Tomohiro Saito,Masahide Mizobuchi,Akane Yamakawa et al. Tomohiro Saito et al.
Background: Statins have little beneficial effects on cardiovascular events (CVEs) in patients undergoing haemodialysis (HD) despite clinically relevant reductions in serum cholesterol levels.
Yutong Wang,Tao Xu,Chenxi Xia et al. Yutong Wang et al.
Associations between cardiorespiratory indices-RHR, HRmax, and VO₂max-and adverse cardiovascular events were evaluated using Cox proportional hazards models. Dose-response relationships were examined via restricted cubic spline (RCS) models with three knots.
Murray F Matangi,Marie-France Hétu,David W J Armstrong et al. Murray F Matangi et al.
Aims: Stress echocardiography (SE), though widely accessible, has some limitations in its diagnostic test characteristics for predicting major adverse cardiovascular events (MACEs).
Gina Domínguez-Armengol,Francesc Ribas-Aulinas,Elisabet Balló et al. Gina Domínguez-Armengol et al.
The primary outcomes will be hard CHD, major adverse cardiovascular events (MACE), all-cause mortality, and improvement in CVD risk factors. Secondary outcomes include CHD (a composite of angina and hard CHD), cerebrovascular disease, and adverse effects from lipid-lowering medication.
Jun Hao,Zhiguang Liu,Bo Hu et al. Jun Hao et al.
In low-exposure areas, higher total physical activity significantly reduced the risk of composite outcome (HR: 0.84, 95% CI: 0.73-0.97, p trend = 0.012) and major cardiovascular events (HR: 0.80, 0.67-0.95, p trend = 0.022)....However, in high-exposure regions, physical activity showed no protective effect for the composite outcome (HR: 0.97, 0.85-1.09, p trend = 0.551) and major cardiovascular events (HR: 0.98, 0.85-1.13, p trend = 0.864).
Maïmouna Touré,Ibrahima Diouf,Fatou Bintou Sar et al. Maïmouna Touré et al.
The latter would be the main basis of the cardiovascular events responsible for the high mortality of rheumatoid arthritis....This could make it possible to predict the risk of cardiovascular events notably high blood pressure in general, and high systolic blood pressure in particular.
Kaarina Rimpeläinen,Fanny Jansson Sigfrids,Daniel Gordin et al. Kaarina Rimpeläinen et al.
We retrieved follow-up data on cardiovascular events and mortality from national registries until the end of 2020....Conclusion: Hypertension during pregnancy is associated with increased risk of cardiovascular events during long-term follow-up in women with T1D, with pre-eclampsia conferring the highest risk.
耗时 0.23626 秒,为您在 48229835 条记录里面共找到 10000 篇文章 [XML]